Health Condition 1: 1- Obstetrics
Conditions
Interventions
Control Intervention1: Noradrenaline: Noradrenaline is both alpha1 and beta 1 agonist cause vesoconstriction with minimum or no change in heart rate.
Route of administration - intravenous
Dose- 4 mic
Sponsors
RGKar Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. ASAI II 2. Patients aged 18 and above . 3. Patients undergoing elective and emergency caesarean section under spinal anaesthesia 4. Patients showing hypotension after spinal anaesthesia
Exclusion criteria
Exclusion criteria: 1. ASA III, IV 2. Any spine abnormalities 3. Patient refusal 4. Patient with bleeding disorder 5. Patient in active labour 6. GDM,PIH 7. Height 180cm 8. Allergy in drug use in thesis. 9. Eclampsia and severely preeclampsia 10. Uncontrolled diabetes 11. Patients with coagulopathy secondary to antiblastic cancer therapy 12. Cardiac or neurological diseases 13. Known allergy to the anaesthetic drugs used 14. Bowl obstruction 15. Systemic sepsis 16. Failed/patchy block will be converted into General Anaesthesia and will not be included in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the effectiveness between Phenylephrine and Noradrenaline via intravenous route in preventing spinal anaesthesia induced hypotension in elective LUCSTimepoint: 6 month after approval of ethical committee | — |
Secondary
| Measure | Time frame |
|---|---|
| To observe any side effectof the drug eg.- bradycardia, tachycardiaTimepoint: 6 month after approval of ethics committee | — |
Countries
India
Contacts
Public ContactDr Arpita Choudhury
R.G.Kar Medical College and Hospital
Outcome results
None listed